Indeed, aside from PSA blood tests, the only other FDA-approved tests for PCa are the detection of the long non-coding RNA (lncRNA) PCA3 in urine [10,11] and, more recently, the SelectMDx test, whose diagnostic performance remains to be clearly established [12]. The gene discussed is KLK3; the disease is posterior cortical atrophy.